Related Experiment Video
Updated: Aug 16, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Emergent strategies in interventional cardiology]
Jiro Aoki1, Gastón A Rodríguez-Granillo, Patrick W Serruys
1Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.
Revista Espanola De Cardiologia
|August 2, 2005
Summary
Sudden cardiac death remains a significant risk in coronary artery disease despite advances. New percutaneous treatments and diagnostic tools offer hope for better plaque detection and myocardial ischemia management.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Sudden cardiac death remains prevalent in coronary artery disease (CAD) patients.
- Ischemic heart disease often requires combined therapies with persistent symptoms.
Purpose of the Study:
- To review recent advances in percutaneous interventions and diagnostic tools for CAD.
- To highlight ongoing research for improved diagnosis and treatment of vulnerable plaque and myocardial ischemia.
Main Methods:
- Review of current and emerging percutaneous interventional treatments.
- Discussion of novel diagnostic tools for vulnerable plaque assessment.
- Exploration of research in therapeutic angiogenesis and myogenesis.
Main Results:
- Development of percutaneous treatments for vulnerable plaque and myocardial ischemia.
- Advancements in catheter-based devices for plaque detection (lipid-rich core, thin fibrous cap, remodeling).
- Emerging research in drug-eluting stents and catheter-based bypass grafts.
Conclusions:
- Percutaneous approaches are expanding diagnostic and therapeutic options for CAD.
- Ongoing research promises further advancements in managing ischemic heart disease and reducing sudden cardiac death.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Cardiac Catheterization IV: Nursing Management
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...